136 related articles for article (PubMed ID: 28112371)
1. MicroRNA-145 inhibits tumorigenesis and invasion of cervical cancer stem cells.
Zhou X; Yue Y; Wang R; Gong B; Duan Z
Int J Oncol; 2017 Mar; 50(3):853-862. PubMed ID: 28112371
[TBL] [Abstract][Full Text] [Related]
2. [LincRNA-ROR functions as a ceRNA to regulate Oct4, Sox2, and Nanog expression by sponging miR-145 and its effect on biologic characteristics of colonic cancer stem cells].
Yan ZY; Sun XC
Zhonghua Bing Li Xue Za Zhi; 2018 Apr; 47(4):284-290. PubMed ID: 29690669
[No Abstract] [Full Text] [Related]
3. microRNA-141-3p fosters the growth, invasion, and tumorigenesis of cervical cancer cells by targeting FOXA2.
Li JH; Zhang Z; Du MZ; Guan YC; Yao JN; Yu HY; Wang BJ; Wang XL; Wu SL; Li Z
Arch Biochem Biophys; 2018 Nov; 657():23-30. PubMed ID: 30222949
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of miR-146a promotes tumorigenesis of cervical cancer stem cells via VEGF/CDC42/PAK1 signaling pathway.
Dong Z; Yu C; Rezhiya K; Gulijiahan A; Wang X
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3711-3719. PubMed ID: 31522559
[TBL] [Abstract][Full Text] [Related]
5. Association of OCT4, SOX2, and NANOG expression with oral squamous cell carcinoma progression.
Fu TY; Hsieh IC; Cheng JT; Tsai MH; Hou YY; Lee JH; Liou HH; Huang SF; Chen HC; Yen LM; Tseng HH; Ger LP
J Oral Pathol Med; 2016 Feb; 45(2):89-95. PubMed ID: 26211876
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-598 inhibits the growth and maintenance of gastric cancer stem-like cells by down-regulating RRS1.
Ma Y; Yan F; Wei W; Deng J; Li L; Liu L; Sun J
Cell Cycle; 2019 Oct; 18(20):2757-2769. PubMed ID: 31438772
[TBL] [Abstract][Full Text] [Related]
7. Tumorigenicity of cancer stem-like cells derived from hepatocarcinoma is regulated by microRNA-145.
Jia Y; Liu H; Zhuang Q; Xu S; Yang Z; Li J; Lou J; Zhang W
Oncol Rep; 2012 Jun; 27(6):1865-72. PubMed ID: 22378186
[TBL] [Abstract][Full Text] [Related]
8. FOXP1 functions as an oncogene in promoting cancer stem cell-like characteristics in ovarian cancer cells.
Choi EJ; Seo EJ; Kim DK; Lee SI; Kwon YW; Jang IH; Kim KH; Suh DS; Kim JH
Oncotarget; 2016 Jan; 7(3):3506-19. PubMed ID: 26654944
[TBL] [Abstract][Full Text] [Related]
9. MiR-1181 inhibits stem cell-like phenotypes and suppresses SOX2 and STAT3 in human pancreatic cancer.
Jiang J; Li Z; Yu C; Chen M; Tian S; Sun C
Cancer Lett; 2015 Jan; 356(2 Pt B):962-70. PubMed ID: 25444909
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Cellular Transforming Activity of OCT4, NANOG, and SOX2 in Immortalized Astrocytes.
Seo S; Jeon HY; Kim H
DNA Cell Biol; 2017 Nov; 36(11):1000-1009. PubMed ID: 28933914
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-101 regulates the viability and invasion of cervical cancer cells.
Lin C; Huang F; Shen G; Yiming A
Int J Clin Exp Pathol; 2015; 8(9):10148-55. PubMed ID: 26617722
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-135a-induced formation of CD133+ subpopulation with cancer stem cell properties in cervical cancer.
Leung CON; Deng W; Ye TM; Ngan HYS; Tsao SW; Cheung ANY; Ziru N; Yuen DCK; Pang RTK; Yeung WSB
Carcinogenesis; 2020 Nov; 41(11):1592-1604. PubMed ID: 32415843
[TBL] [Abstract][Full Text] [Related]
13. [Yamanaka's factors and core transcription factors--the molecular link between embryogenesis and carcinogenesis].
Fuławka Ł; Donizy P; Hałoń A
Postepy Hig Med Dosw (Online); 2014 Jun; 68():715-21. PubMed ID: 24934529
[TBL] [Abstract][Full Text] [Related]
14. microRNA-328 inhibits cervical cancer cell proliferation and tumorigenesis by targeting TCF7L2.
Wang X; Xia Y
Biochem Biophys Res Commun; 2016 Jun; 475(2):169-75. PubMed ID: 27181358
[TBL] [Abstract][Full Text] [Related]
15. MiR-125a suppresses tumor growth, invasion and metastasis in cervical cancer by targeting STAT3.
Fan Z; Cui H; Xu X; Lin Z; Zhang X; Kang L; Han B; Meng J; Yan Z; Yan X; Jiao S
Oncotarget; 2015 Sep; 6(28):25266-80. PubMed ID: 26389681
[TBL] [Abstract][Full Text] [Related]
16. miR-27b is upregulated in cervical carcinogenesis and promotes cell growth and invasion by regulating CDH11 and epithelial-mesenchymal transition.
Yao J; Deng B; Zheng L; Dou L; Guo Y; Guo K
Oncol Rep; 2016 Mar; 35(3):1645-51. PubMed ID: 26706910
[TBL] [Abstract][Full Text] [Related]
17. Linc-RNA-RoR acts as a "sponge" against mediation of the differentiation of endometrial cancer stem cells by microRNA-145.
Zhou X; Gao Q; Wang J; Zhang X; Liu K; Duan Z
Gynecol Oncol; 2014 May; 133(2):333-9. PubMed ID: 24589415
[TBL] [Abstract][Full Text] [Related]
18. microRNA-145 promotes differentiation in human urothelial carcinoma through down-regulation of syndecan-1.
Fujii T; Shimada K; Tatsumi Y; Hatakeyama K; Obayashi C; Fujimoto K; Konishi N
BMC Cancer; 2015 Oct; 15():818. PubMed ID: 26514209
[TBL] [Abstract][Full Text] [Related]
19. Crosstalks between Raf-kinase inhibitor protein and cancer stem cell transcription factors (Oct4, KLF4, Sox2, Nanog).
Lee S; Wottrich S; Bonavida B
Tumour Biol; 2017 Apr; 39(4):1010428317692253. PubMed ID: 28378634
[TBL] [Abstract][Full Text] [Related]
20. Syndecan-1 responsive microRNA-126 and 149 regulate cell proliferation in prostate cancer.
Fujii T; Shimada K; Tatsumi Y; Fujimoto K; Konishi N
Biochem Biophys Res Commun; 2015 Jan; 456(1):183-9. PubMed ID: 25462564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
